MedCity News June 16, 2022
Joel Berg

The nonprofit Digital Medicine Society is partnering with the likes of Google and the FDA to develop a free resource designed to help digital health startups navigate the regulatory process.

A new effort is aimed at helping digital health startups bake regulatory considerations into their business strategy early on – and spare them from nasty surprises when they seek approvals for their products.

By early 2023, the Digital Health Regulatory Pathways project plans to unveil a free, open-access resource that will guide startups along the right regulatory path. Boston-based Digital Medicine Society, or DiMe, is sponsoring the project, which was announced this week.

Regulators have made headway, particularly in the U.S., toward embracing the new generation of digital health...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, FDA, Govt Agencies, Regulations, Technology
Women's virtual care clinic Midi Health raises $60M
Joint Commission launches accreditation standards for telehealth
Nutrition app MyFitnessPal announces tools for GLP-1 medication support
Summer Health pockets $12M series A to grow text-based pediatric service
Hospitals Outside of US Investing in Portals and Digital Front Door According to Latest KLAS Report

Share This Article